Back to search

Article

Long-term N-Acetylcysteine Treatment Accelerates Improvement in Patient-Reported Outcomes for COVID-19 Patients: A Randomized, Double-Blind, Placebo-Controlled Trial

2025-12-12

Abstract excerpt

<h4>Objectives</h4> The coronavirus disease 2019 (COVID-19) pandemic has necessitated the urgent investigation of effective long-term therapeutic agents. This study aimed to evaluate the definitive, long-term causal effect of N-acetylcysteine (NAC) treatment on patient-reported outcomes (PRO) in patients with COVID-19 from hospital admission to six months after discharge. <h4>Design</h4> Prospective, multi-cente...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ea63babb-1d9d-505f-99a0-d08f2d6c69d9
DOI
10.64898/2025.12.10.25342003
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Long-term N-Acetylcysteine Treatment Accelerates Improvement in Patient-Reported Outcomes for COVID-19 Patients: A Randomized, Double-Blind, Placebo-Controlled TrialDOI 10.64898/2025.12.10.25342003
Effect of Intravenous N-acetylcysteine on Prevention of Mechanical Ventilation and Mortality among COVID-19 Patients: A Meta-AnalysisSemantic proximity
HYDROXYCHLOROQUINE FOR THE TREATMENT OF SEVERE RESPIRATORY INFECTION BY COVID-19: A RANDOMIZED CONTROLLED TRIALSemantic proximity
Clinical and Non-clinical Proof of Concept Supporting the Development of RJX As an Adjunct to Standard of Care Against Severe COVID-19Semantic proximity
Chinese Clinical Studies for Pharmacological Treatments of Coronavirus Disease 2019 (COVID-19)Semantic proximity
Effects of Pycnogenol<sup>®</sup>in post-COVID-19 condition (PYCNOVID): A single-center, placebo controlled, quadruple-blind, randomized trialSemantic proximity
A randomized, double-blind, controlled trial of convalescent plasma in adults with severe COVID-19Semantic proximity
eNACT: A protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first episode psychosisSemantic proximity
Comparative Effectiveness and Safety of 32 Pharmacological Interventions Recommended by Guidelines for COVID-19: A Systematic Review and Network Meta-Analysis Combining 66 TrialsSemantic proximity
Oral corticosteroids for post-infectious cough in adults: study protocol for a double-blind randomized placebo-controlled trial in Swiss family practices (OSPIC trial)Semantic proximity
Effects of Specialized Pro-Resolving Mediators and Telerehabilitation on Fatigue, Dyspnea, and Quality of Life in Post‑COVID‑19 Condition: The ARACOV-02 Randomized Controlled Trial.Semantic proximity
Efficacy of clarithromycin on COVID-19 pneumonia without oxygen administration; protocol for multicenter, open-label, randomized-controlled, 3-armed parallel group comparison, exploratory trial (CAME COVID study)Semantic proximity
Protocol for a randomized controlled trial testing inhaled nitric oxide therapy in spontaneously breathing patients with COVID-19Semantic proximity
Select a neighboring publication to make it the new centre.